针对心血管疾病治疗的阿佩林系统
Fiona A Chapman1,2, Janet J Maguire3, David E Newby1
1BHF/University of Edinburgh Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh, UK.
Cardiovascular research
|November 13, 2023
概括
阿佩林系统是心血管功能的关键调节器,为心脏,脏和代谢疾病提供了新的治疗潜力. 激活阿佩林受体在治疗心血管疾病方面表现有前途.
科学领域:
- 生理学 生理学 生理学
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 心血管疾病患病率上升与人口老龄化和慢性病,肥胖和糖尿病等并发症有关.
- 目前对心血管疾病的治疗造成了重大负担,需要新的治疗策略.
研究的目的:
- 审查阿佩林系统在心血管生理学中的作用.
- 探索针对心血管,脏和代谢疾病的阿佩林系统的治疗潜力.
- 讨论阿佩林受体激动症作为未来的临床策略.
主要方法:
- 对阿佩林系统的生理功能进行文献综述.
- 对阿佩林受体激活的临床前和临床数据的分析.
- 检查阿佩林系统与其他关键生理系统的相互作用.
主要成果:
- 阿佩林系统,包括阿佩林和埃拉贝拉连接体以及阿佩林受体,调节血压,内和血管度.
- 阿佩林受体的激活促进血管扩张,血管生成和尿路,同时抑制血栓形成和炎症.
- 该系统反对renin-angiotensin和血管压素系统的作用.
结论:
- 阿佩林系统是对一系列心血管,脏和代谢疾病的有前途的治疗点.
- 阿佩林受体激素具有新治疗方法的潜力,可以减少与这些疾病相关的发病率和死亡率.
- 对阿佩林受体激动剂的临床功效进行进一步的研究是有必要的.
相关概念视频
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Angina IV: Management
9
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9


